Literature DB >> 9153249

Utilization of recombinant adenovirus and dominant negative mutants to characterize hepatocyte nuclear factor 4-regulated apolipoprotein AI and CIII expression.

J D Fraser1, D Keller, V Martinez, D Santiso-Mere, R Straney, M R Briggs.   

Abstract

Using recombinant adenoviral vectors and a dominant negative mutant of HNF-4, we have examined the contribution of hepatocyte nuclear factor 4 (HNF-4) to endogenous apolipoprotein AI and CIII mRNA expression. Overexpression of HNF-4 leads to a 7.4-fold increase in apolipoprotein CIII expression, while infection with the dominant negative mutant of HNF-4 reduces the level of apolipoprotein CIII mRNA by 80%, demonstrating that endogenous HNF-4 is necessary for apolipoprotein CIII expression. Experiments using the hepatoma cell lines, HepG2 and Hep3B, indicate that HNF-4 is also involved in the regulation of apolipoprotein AI expression in these lines. However, the effect of HNF-4 on apolipoprotein AI expression is much more dramatic in cell lines derived from intestinal epithelium. Infection of the intestinal-derived cell line IEC-6 with the HNF-4 adenovirus resulted in a greater than 20-fold increase in the level of apolipoprotein AI mRNA. These results indicate that HNF-4 does regulate apolipoprotein AI and CIII mRNA expression and suggest that HNF-4 is critical for intestinal apolipoprotein AI expression.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9153249     DOI: 10.1074/jbc.272.21.13892

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  12 in total

1.  DNA binding and transcription activation specificity of hepatocyte nuclear factor 4.

Authors:  J D Fraser; V Martinez; R Straney; M R Briggs
Journal:  Nucleic Acids Res       Date:  1998-06-01       Impact factor: 16.971

2.  Negative autoregulation of HNF-4alpha gene expression by HNF-4alpha1.

Authors:  Judith Magenheim; Rachel Hertz; Ina Berman; Janna Nousbeck; Jacob Bar-Tana
Journal:  Biochem J       Date:  2005-05-15       Impact factor: 3.857

3.  The full induction of human apoprotein A-I gene expression by the experimental nephrotic syndrome in transgenic mice depends on cis-acting elements in the proximal 256 base-pair promoter region and the trans-acting factor early growth response factor 1.

Authors:  M Zaiou; N Azrolan; T Hayek; H Wang; L Wu; M Haghpassand; B Cizman; M P Madaio; J Milbrandt; J B Marsh; J L Breslow; E A Fisher
Journal:  J Clin Invest       Date:  1998-04-15       Impact factor: 14.808

Review 4.  High density lipoprotein, apolipoprotein A-I, and coronary artery disease.

Authors:  R A Srivastava; N Srivastava
Journal:  Mol Cell Biochem       Date:  2000-06       Impact factor: 3.396

5.  Naturally occurring mutations in the human HNF4alpha gene impair the function of the transcription factor to a varying degree.

Authors:  J Lausen; H Thomas; I Lemm; M Bulman; M Borgschulze; A Lingott; A T Hattersley; G U Ryffel
Journal:  Nucleic Acids Res       Date:  2000-01-15       Impact factor: 16.971

6.  Adenovirus-mediated increase of HNF-3 levels stimulates expression of transthyretin and sonic hedgehog, which is associated with F9 cell differentiation toward the visceral endoderm lineage.

Authors:  Y Tan; R H Costa; I Kovesdi; R R Reichel
Journal:  Gene Expr       Date:  2001

7.  Signalling cross-talk between hepatocyte nuclear factor 4alpha and growth-hormone-activated STAT5b.

Authors:  Soo-Hee Park; Christopher A Wiwi; David J Waxman
Journal:  Biochem J       Date:  2006-07-01       Impact factor: 3.857

8.  An array of binding sites for hepatocyte nuclear factor 4 of high and low affinities modulates the liver-specific enhancer for the human alpha1-microglobulin/bikunin precursor.

Authors:  P Rouet; G Raguenez; P Ruminy; J P Salier
Journal:  Biochem J       Date:  1998-09-15       Impact factor: 3.857

9.  Retinoids increase human apo C-III expression at the transcriptional level via the retinoid X receptor. Contribution to the hypertriglyceridemic action of retinoids.

Authors:  N Vu-Dac; P Gervois; I P Torra; J C Fruchart; V Kosykh; T Kooistra; H M Princen; J Dallongeville; B Staels
Journal:  J Clin Invest       Date:  1998-08-01       Impact factor: 14.808

10.  Liver-type fatty acid binding protein interacts with hepatocyte nuclear factor 4α.

Authors:  Avery L McIntosh; Anca D Petrescu; Heather A Hostetler; Ann B Kier; Friedhelm Schroeder
Journal:  FEBS Lett       Date:  2013-10-15       Impact factor: 4.124

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.